Endocrinology, Vol 129, 368-374, Copyright © 1991 by Endocrine Society

ARTICLES

Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro

GW Mulheron, D Danielpour and DW Schomberg
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710.

We previously demonstrated that granulosa cells from diethylstilbestrol- primed immature rats expressed transforming growth factor-beta 2 (TGF beta 2), but not TGF beta 1, mRNA and that its expression was regulated by FSH in vitro. The present studies were designed, therefore, to establish whether thecal/interstitial cells (TIC) from diethylstilbestrol-primed immature rats express more than one subtype of TGF beta mRNA and gene product and whether the levels of expression/production in vitro were regulated by LH/hCG. Reverse transcription-polymerase chain reaction (RT-PCR) analysis of total RNA indicated that TIC expressed both TGF beta 1 and TGF beta 2 mRNA. In response to hCG (200 ng/ml), TIC expressed TGF beta 2 mRNA levels that were 51% of control levels; TGF beta 1 mRNA levels were not altered. In response to cholera toxin (10(-9) M), TIC expression of TGF beta 2 and TGF beta 1 mRNA levels was 10% and 55% of control values, respectively. Western blot analysis established that both TGF beta 1 and TGF beta 2 were secreted in vitro. hCG and cholera toxin reduced secretion of TGF beta bioactivity by 55% and 90%, respectively. In summary, these results indicate: 1) TIC express both TGF beta 1 and TGF beta 2 mRNA; 2) TIC expression of TGF beta 2, but not TGF beta 1, mRNA is regulated by hCG in vitro; 3) TIC secrete both TGF beta 1 and TGF beta 2, and 4) TIC secretion in vitro of TGF beta activity is gonadotropin regulated.

This article has been cited by other articles:

				X. Gueripel, M. Benahmed, and A. Gougeon Sequential Gonadotropin Treatment of Immature Mice Leads to Amplification of Transforming Growth Factor {beta} Action, Via Upregulation of Receptor-Type 1, Smad 2 and 4, and Downregulation of Smad 6 Biol Reprod, March 1, 2004; 70(3): 640 - 648. [Abstract] [Full Text] [PDF]

				G. Kohli, S. Hu, E. Clelland, T. Di Muccio, J. Rothenstein, and C. Peng Cloning of Transforming Growth Factor-{beta}1 (TGF-{beta}1) and Its Type II Receptor from Zebrafish Ovary and Role of TGF-{beta}1 in Oocyte Maturation Endocrinology, May 1, 2003; 144(5): 1931 - 1941. [Abstract] [Full Text] [PDF]

				C. R. Harlow, M. Rae, L. Davidson, P. C. Trackman, and S. G. Hillier Lysyl Oxidase Gene Expression and Enzyme Activity in the Rat Ovary: Regulation by Follicle-Stimulating Hormone, Androgen, and Transforming Growth Factor-{beta} Superfamily Members in Vitro Endocrinology, January 1, 2003; 144(1): 154 - 162. [Abstract] [Full Text] [PDF]

				M. Paciga, A. J. Watson, G. E. DiMattia, and G. F. Wagner Ovarian Stanniocalcin Is Structurally Unique in Mammals and Its Production and Release Are Regulated through the Luteinizing Hormone Receptor Endocrinology, October 1, 2002; 143(10): 3925 - 3934. [Abstract] [Full Text] [PDF]

				R. J. Zachow, S. R. Weitsman, and D. A. Magoffin Leptin Impairs the Synergistic Stimulation by Transforming Growth Factor-{beta} of Follicle-Stimulating Hormone-Dependent Aromatase Activity and Messenger Ribonucleic Acid Expression in Rat Ovarian Granulosa Cells Biol Reprod, October 1, 1999; 61(4): 1104 - 1109. [Abstract] [Full Text]

				M. E. Gordinier, H.-Z. Zhang, R. Patenia, L. B. Levy, E. N. Atkinson, M. A. Nash, R. L. Katz, C. D. Platsoucas, and R. S. Freedman Quantitative Analysis of Transforming Growth Factor {beta}1 and 2 in Ovarian Carcinoma Clin. Cancer Res., September 1, 1999; 5(9): 2498 - 2505. [Abstract] [Full Text] [PDF]

				A. Colman-Lerner, M. L. Fischman, G. M. Lanuza, D. M. Bissell, A. R. Kornblihtt, and J. L. Barañao Evidence for a Role of the Alternatively Spliced ED-I Sequence of Fibronectin during Ovarian Follicular Development Endocrinology, June 1, 1999; 140(6): 2541 - 2548. [Abstract] [Full Text]